• Solitary Plasmacytoma0
• Newly Diagnosed3
• Recurrent / Refractory3
• Post Transplant / Maintenance0
• Amyloidosis0
• Transplant0
• Waldenstrom's0

• Protocols

• HO07403

  OPEN TO ACCRUAL

  Collection Protocol of Bone Marrow Tumor Cells and Stromal Cells from MM Patients
  
  

• S2213

  OPEN TO ACCRUAL

  Ph 3 Study of Dara-VCD Induct + Auto-SCT or Dara-VCD + Dara Maintenance in Pts w ND AL Amyloidosis
  
  

• UW22075

  OPEN TO ACCRUAL

  Ph 1b,2 of BGB-11417 in Monotherapy and in Combinations with Dexamethasone and Carfilzomib in R,R MM
  
  

• UW23044

  OPEN TO ACCRUAL

  EAP for Cilta-Cel OOS in Multiple Myeloma
  
  

• UW23048

  OPEN TO ACCRUAL

  EAP For Nonconforming Lisocabtagene Maraleucel
  
  

• UW23143

  OPEN TO ACCRUAL

  A Phase 2 Study of a GPRC5D-directed CAR T Cell Therapy in Participants with RRMM
  
  

• UW24024

  OPEN TO ACCRUAL

  MRD-Guided Sequential Therapy for Deep Response in NDMM - MASTER-2 MM 160
  
  

• UW24123

  OPEN TO ACCRUAL

  Phase Ib and II SCID trial for RRMM - BTCRC-MM21-528
  
  

• UW25007

  OPEN TO ACCRUAL

  Ph 3 Study of Tec+Len and Tec Alone vs. Len Alone in NDMM as Maintenance Following ASCT - MajesTEC-4
  
  

• UW25037

  OPEN TO ACCRUAL

  Ph 2 T-cell engager vs ASCT+MRD-guided therapy in multiple myeloma - FASTER MM195